Story perspectives

Trump’s Axon Stock Purchase Sparks Ethics Reform Calls

6/30/2026

Summary

Trump Buys Axon

U.S. President Donald Trump bought $1-$5 million of Axon stock on Feb. 10, 2026, two weeks before ICE issued a $220 million Taser procurement notice.
Axon shares rose 9.85 % to $510.60 on June 29, 2026, after the Trump disclosure.
The stock rose over 34 % the week after the ICE notice, topping $516 after hours.
Ethics groups call for STOCK Act reforms, citing conflict-of-interest concerns over the timing.

Summary

Trump Uses Trust

The White House says U.S. President Donald Trump’s assets are in a trust run by his children and independent firms, with no investment role.
Eric Trump said external managers run the holdings without input, while ethics scholars note a two-week gap before Immigration and Customs Enforcement (ICE)’s $220 million solicitation creates a conflict.
Procurement experts say ICE’s requirements mirror Axon’s TASER 10, the supplier, as White House and Trump family deny wrongdoing.

Summary

Trump Clears Axon

U.S. President Donald Trump’s Axon purchase is not illegal because law exempts the president from conflict statutes.
Axon posted Q1 revenue of $807 million, a 34 % YoY rise, calling 2026 a bumper federal year.
It holds a $370 million Department of Homeland Security (DHS) body-camera contract, with $67.5 million already deployed.
Axon sells cloud evidence, AI, drones and real-time command tools after spending $5 million on lobbying and hiring a former senior Palantir employee.

History

Historical Context

The STOCK Act, signed by President Barack Obama on April 4 2012, required Congress and senior officials to report securities trades within 30-45 days, leading to about 4,000 disclosed trades worth $315 million by September 2021. That reporting regime frames criticism of President Donald Trump’s February 2026 Axon purchase, disclosed two weeks before ICE’s $220 million Taser solicitation.

1 of 4

Trump Buys Axon

U.S. President Donald Trump bought $1-$5 million of Axon stock on Feb. 10, 2026, two weeks before ICE issued a $220 million Taser procurement notice.
Axon shares rose 9.85 % to $510.60 on June 29, 2026, after the Trump disclosure.
The stock rose over 34 % the week after the ICE notice, topping $516 after hours.
Ethics groups call for STOCK Act reforms, citing conflict-of-interest concerns over the timing.

1 / 4